LONDON (Reuters) - London-based Lansdowne Partners is closing its main hedge fund, a long-short strategy that manages $2.8 billion in assets under management, a person familiar...
Keep Reading →
July 7 - Hedge Funds, Insider Trading - Comments
The public and oftentimes nasty wars waged by activist investors this decade are personified by the 2013 “Battle of the Billionaires” on CNBC.
Keep Reading →
December 13 - Hedge Funds, Insider Trading - Comments
Steve Cohen’s Point72 Asset Management returned about 1 percent in 2016, the second-worst annual performance ever for the billionaire investor, according to people familiar ...
Keep Reading →
January 13 - Hedge Funds - Comments
The vultures were circling Leon Cooperman's biggest positions after the SEC announced at 10:47 a.m.
Keep Reading →
September 21 - Hedge Funds - Comments
Pershing Square Holdings, the publicly traded security of activist investor Bill Ackman’s hedge fund, disclosed its second-quarter results Wednesday morning.
Keep Reading →
July 20 - Hedge Funds - Comments
Jacob Gottlieb’s multi-billion-dollar hedge fund Visium Asset Management LP has been making headlines earlier today, as federal authorities filed criminal and civil securities...
Keep Reading →
June 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
We are seeing a boatload of 13G filing activity at the moment and investment firms disclose their positions as of the end of 2015 (we are not publishing these filings, as they...
Keep Reading →
February 12 - Hedge Funds, News - Comments
Numerous sources and statistics recently indicated that hedge funds have been severely hit by the current volatile markets.
Keep Reading →
February 12 - Hedge Funds, News - Comments
Jacob Gottlieb’s Visium Asset Management recently filed its latest 13F with the Securities and Exchange Commission for the reporting period of September 30.
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than 5% in a publicly-traded...
Keep Reading →
December 1 - Hedge Funds, News - Comments
Is it a good time to buy shares of Ascendis Pharma A/S (NASDAQ:ASND)? Jacob Gottlieb thinks so, since his fund, Visium Asset Management, has significantly increased its holding...
Keep Reading →
September 1 - Hedge Funds, News - Comments
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV Technologies S.A.
Keep Reading →
August 11 - Hedge Funds, News - Comments
Jacob Gottlieb is the manager and founder of Visium Asset Management.
Keep Reading →
July 1 - Hedge Funds, News - Comments
Visium Asset Management has submitted its 13F filing with the SEC for the reporting period of March 31.
Keep Reading →
May 29 - Hedge Funds, News - Comments
Jacob Gottlieb’s Visium Asset Management, Richard Gerson and Navroz D.
Keep Reading →
April 29 - Hedge Funds, News - Comments
The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported positions in companies with...
Keep Reading →
April 10 - Hedge Funds, News - Comments
Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.
Keep Reading →
March 31 - Hedge Funds, News - Comments
Jacob Gottlieb's Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the Securities and Exchange Commission...
Keep Reading →
March 3 - Hedge Funds, News - Comments
Bihua Chen’s Cormorant Asset Management disclosed, last Thursday, that it had tripled its exposure to Quotient Ltd (NASDAQ:QTNT), from 500,000 shares held by the end of the ...
Keep Reading →
December 5 - Hedge Funds, News - Comments
In the last few days, we have seen a lot of capital from funds that we track getting shifted to pharmaceutical stocks and no it’s not just sector specific funds, but funds across...
Keep Reading →
October 21 - Hedge Funds, News - Comments
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in.
Keep Reading →
October 20 - Hedge Funds, News - Comments
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with Mr.
Keep Reading →
October 7 - Hedge Funds, News - Comments
Two Schedule 13G forms filed with the SEC yesterday called my attention.
Keep Reading →
October 3 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has boosted its stake in CONMED Corporation (NASDAQ:CNMD). In a new filing with the U.S.
Keep Reading →
September 23 - Hedge Funds, News - Comments
Wright Medical Group Inc (NASDAQ:WMGI)'s stake in Jacob Gottlieb's Visium Asset Management's equity portfolio has been slightly increased, as a new filing with the SEC showed...
Keep Reading →
September 12 - Hedge Funds, News - Comments
In a new round of filing with the Securities and Exchange Commission, Huber Capital Management has disclosed the acquisition of some more Cal Dive International, Inc.
Keep Reading →
September 11 - Hedge Funds, News - Comments
Amidst the 13F filing season, several hedge funds have also been filing Schedule 13G forms, disclosing changes that took place after June 30, 2014, in their equity positions.
Keep Reading →
August 21 - Hedge Funds, News - Comments
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.
Keep Reading →
August 11 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has boosted its position in Horizon Pharma Inc. (NASDAQ:HZNP), a new filing with the U.S.
Keep Reading →
August 11 - Hedge Funds, News - Comments
Jacob Gottlieb is very bullish on The Spectranetics Corporation (NASDAQ:SPNC) and has increased his fund's stake by more than 300%, as reported in a recent filing with the Securities...
Keep Reading →
July 25 - Hedge Funds, News - Comments
Jacob Gottlieb thinks OHR Pharmaceutical Inc (NASDAQ:OHRP) is a good investment and has initiated a new position for his fund, Visium Asset Management.
Keep Reading →
July 14 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has disclosed a new position in Quotient Ltd (NASDAQ:QTNT). A new filing with the U.S.
Keep Reading →
June 30 - Hedge Funds, News - Comments
In the latest round of 13F filings, last week, Israel Englander’s Millennium Management has filed its form 13F with the U.S. Securities and Exchange Commission.
Keep Reading →
May 20 - Hedge Funds, News - Comments
Jacob Gottlieb and his fund, Visium Asset Management, have upped their interest in Brookdale Senior Living, Inc.
Keep Reading →
April 23 - Hedge Funds, News - Comments
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals Inc.
Keep Reading →
April 17 - Hedge Funds, News - Comments
While some investors focused on large-cap healthcare stocks during the fourth quarter of 2013, such as the purchase of HCA Holdings Inc (NYSE:HCA) by Larry Robbins' Glenview ...
Keep Reading →
March 25 - Hedge Funds, News - Comments
Coliseum Capital, managed by Christopher Shackelton and Adam Gray, has disclosed a new 6.2% stake in Medifast Inc (NYSE:MED).
Keep Reading →
March 19 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).
Keep Reading →
March 19 - Hedge Funds, News - Comments
Steven Cohen of S.A.C Capital Advisors has increased its passive stake in Annie's Inc (NYSE:BNNY), a recent 13G filing shows. Mr.
Keep Reading →
March 17 - Hedge Funds, News - Comments
Steven Cohen’s SAC Capital Advisors has reported adding Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) to its equity portfolio.
Keep Reading →
March 13 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Keep Reading →
March 7 - Hedge Funds, News - Comments
Visium Asset Management, led by Jacob Gottlieb, has added NephroGenex Inc (NASDAQ:NRX) and Ignyta Inc (OTCBB:RXDX) to its equity portfolio.
Keep Reading →
February 21 - Hedge Funds, News - Comments
Citadel Investment Group, managed by Ken Griffin, has revealed, in a couple of new filings with the Securities and Exchange Commission tweaking its holdings in RF Micro Devices...
Keep Reading →
February 4 - Hedge Funds, News - Comments
After each quarter, hedge funds and other major investors disclose many of their long equity positions with the U.S. Securities and Exchange Commission.
Keep Reading →
February 4 - Hedge Funds, News - Comments
Kevin C. Tang's Tang Capital Management has decreased its position it two pharmaceutical companies.
Keep Reading →
January 17 - Hedge Funds, News - Comments
Julian and Felix Baker's Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier.
Keep Reading →
January 2 - Hedge Funds, News - Comments
The position of Zogenix, Inc.
Keep Reading →
November 29 - Hedge Funds, News - Comments
Over the past week, insider activity at two pharmaceutical companies, IDEXX Laboratories, Inc. (NASDAQ:IDXX) and Onconova Therapeutics Inc (NASDAQ:ONTX), caught my eye.
Keep Reading →
November 26 - Insider Trading, News - Comments
Jacob Gottlieb's hedge fund, Visium Asset Management, has boosted its position in biotechnology company QLT Inc. (USA) (NASDAQ:QLTI), a new filing with the SEC revealed.
Keep Reading →
November 25 - Hedge Funds, News - Comments
Jacob Gottlieb, MEI Pharma: A couple of minutes ago, Jacob Gottlieb's hedge fund Visium Asset Management reported initiating a new position in MEI Pharma Inc (NASDAQ:MEIP).
Keep Reading →
October 16 - Hedge Funds, News - Comments
